ResearcherThird Xiangya HospitalNo recent work listed

Wanwan Li

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper

Papers 1

Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/tcr.2018.12.20 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chen Yang · 1 shared paper, 2019 · strength 0.11
- Paper Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcin… DOI 10.21037/tcr.2018.12.20 ↗
Xiaorong Li · 1 shared paper, 2019 · strength 0.11
- Paper Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcin… DOI 10.21037/tcr.2018.12.20 ↗
Guanghai Dai · 1 shared paper, 2019 · strength 0.11
- Paper Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcin… DOI 10.21037/tcr.2018.12.20 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.